<p>Distribution of CD45.1+ and CD45.2+ cells in the bone marrow of recipient mice 3 months after bone marrow transplantation. CD45.1+ WT and CD45.2+ WT or CD45.2+ KO donor cells were mixed at a 1∶1 ratio prior to injection into recipient CD45.1+ mice. The percentage of total cells gated and the percentage of CD45.1+ or CD45.2+ cells for any given gate are shown. Significance was assessed using Student’s t-test and p-values are indicated as. *p<0.05, **p<0.01, ***p<0.001.</p
<p>NSG mice received intrafemoral transplantation of stromal cells into the left femur followed by i...
<p>Analyses were performed on day 14 after second transplantation. (A) Continuous HSCT: To evaluate ...
<p>Two groups of NSG mice (n = 5 each) received 50×10<sup>3</sup> bone marrow derived CD34 positive ...
<p>Distribution of CD45.1+ and CD45.2+ cells in the lymph node of recipient mice 3 months after bone...
<p>Distribution of CD45.1+ and CD45.2+ cells in the thymus of recipient mice 3 months after bone mar...
<p>Distribution of CD45.1+ and CD45.2+ cells in the spleen of recipient mice 3 months after bone mar...
<p>Distribution of CD45.1+ and CD45.2+ cells in the peritoneal cavity of recipient mice 3 months aft...
<p>The percentage of donor-derived hematopoietic cells in bone marrow cells of recipient tolerant mi...
<p>CD45+ cells recovered from bone marrow harvested from NSG mice 12–15 week post transplantation wi...
<p>(A, D) Schematics of bone marrow transplants. Recipient mice received two doses of lethal irradia...
<p>(A) and (B) Two months following BM transplantation, the four groups of mice were sacrificed and ...
<p>(A) Re-transplantation: In order to evaluate the effects of GvHD on BM niche, recipient mice in t...
<p>Cohorts of Rag-1<sup>−/−</sup> mice were irradiated with given a transplant of 10<sup>3</sup> bon...
<p>Cohorts of NSG mice were irradiated with given a transplant of cord blood cells or G-CSF mobilize...
<p>A) Scheme of the <i>in vivo</i> competitive repopulation assay. B) Representative flow cytometric...
<p>NSG mice received intrafemoral transplantation of stromal cells into the left femur followed by i...
<p>Analyses were performed on day 14 after second transplantation. (A) Continuous HSCT: To evaluate ...
<p>Two groups of NSG mice (n = 5 each) received 50×10<sup>3</sup> bone marrow derived CD34 positive ...
<p>Distribution of CD45.1+ and CD45.2+ cells in the lymph node of recipient mice 3 months after bone...
<p>Distribution of CD45.1+ and CD45.2+ cells in the thymus of recipient mice 3 months after bone mar...
<p>Distribution of CD45.1+ and CD45.2+ cells in the spleen of recipient mice 3 months after bone mar...
<p>Distribution of CD45.1+ and CD45.2+ cells in the peritoneal cavity of recipient mice 3 months aft...
<p>The percentage of donor-derived hematopoietic cells in bone marrow cells of recipient tolerant mi...
<p>CD45+ cells recovered from bone marrow harvested from NSG mice 12–15 week post transplantation wi...
<p>(A, D) Schematics of bone marrow transplants. Recipient mice received two doses of lethal irradia...
<p>(A) and (B) Two months following BM transplantation, the four groups of mice were sacrificed and ...
<p>(A) Re-transplantation: In order to evaluate the effects of GvHD on BM niche, recipient mice in t...
<p>Cohorts of Rag-1<sup>−/−</sup> mice were irradiated with given a transplant of 10<sup>3</sup> bon...
<p>Cohorts of NSG mice were irradiated with given a transplant of cord blood cells or G-CSF mobilize...
<p>A) Scheme of the <i>in vivo</i> competitive repopulation assay. B) Representative flow cytometric...
<p>NSG mice received intrafemoral transplantation of stromal cells into the left femur followed by i...
<p>Analyses were performed on day 14 after second transplantation. (A) Continuous HSCT: To evaluate ...
<p>Two groups of NSG mice (n = 5 each) received 50×10<sup>3</sup> bone marrow derived CD34 positive ...